Literature DB >> 24595786

Deaths and cardiovascular events in men receiving testosterone.

James Katz1, Robert Nadelberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24595786     DOI： 10.1001/jama.2014.395

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?

Authors:  Monique S Tanna; Arthur Schwartzbard; Jeffery S Berger; Joseph Alukal; Howard Weintraub
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

Review 2.  A biopsychosocial approach to women's sexual function and dysfunction at midlife: A narrative review.

Authors:  Holly N Thomas; Rebecca C Thurston
Journal:  Maturitas       Date:  2016-02-21       Impact factor: 4.342

3.  Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis.

Authors:  Jemma Hudson; Moira Cruickshank; Richard Quinton; Lorna Aucott; Magaly Aceves-Martins; Katie Gillies; Shalender Bhasin; Peter J Snyder; Susan S Ellenberg; Mathis Grossmann; Thomas G Travison; Emily J Gianatti; Yvonne T van der Schouw; Marielle H Emmelot-Vonk; Erik J Giltay; Geoff Hackett; Sudarshan Ramachandran; Johan Svartberg; Kerry L Hildreth; Kristina Groti Antonic; Gerald B Brock; J Lisa Tenover; Hui Meng Tan; Christopher Ho Chee Kong; Wei Shen Tan; Leonard S Marks; Richard J Ross; Robert S Schwartz; Paul Manson; Stephen Roberts; Marianne Skovsager Andersen; Line Velling Magnussen; Rodolfo Hernández; Nick Oliver; Frederick Wu; Waljit S Dhillo; Siladitya Bhattacharya; Miriam Brazzelli; Channa N Jayasena
Journal:  Lancet Healthy Longev       Date:  2022-06

4.  An update on testosterone, HDL and cardiovascular risk in men.

Authors:  Arthi Thirumalai; Katya B Rubinow; Stephanie T Page
Journal:  Clin Lipidol       Date:  2015

Review 5.  Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.

Authors:  Baris Gencer; Marco Bonomi; Maria Pia Adorni; Cesare R Sirtori; François Mach; Massimiliano Ruscica
Journal:  Rev Endocr Metab Disord       Date:  2021-02-22       Impact factor: 6.514
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.